Pharma News

BCIL seeks partner to commercialise typhoid vaccine

  • Posted on: 13 February 2020
  • By: PharmaTutor News

The Department of Biotechnology’s Biotech Consortium India Limited (BCIL) is looking for an industrial partner for commercialization of a technology for producing a Bivalent Outer Membrane Vesicles (OMV) vaccine against typhoid. Typhoid fever usually occurs in children aged between 5–15 years.

Way paved for a new treatment for Alzheimer like conditions

  • Posted on: 13 February 2020
  • By: PharmaTutor News

The immune system in the body has an important component called the `complement system’. This is involved in immune surveillance. It is important that it is regulated properly. Otherwise, it can damage the cells of the host’s body itself. This problem is linked to several diseases, including Alzheimer’s, stroke, age-related macular degeneration, asthma, rheumatoid arthritis and cancer.

Association of Inspectors of Drugs seek promotion and asked government to fill vacant posts

  • Posted on: 13 February 2020
  • By: PharmaTutor News

Association of Inspectors of Drugs (AIDA), Assam is requested to Assam Health & Family welfare for urgent sitting of DPC and appointment of controlling and Licensing Authority of Drugs control organization. They have also requested for promotion and asked government to fill vacant posts

NIH-Funded Clinical Trial to Test PrEP, Dapivirine Ring for Safety in Pregnant Women

  • Posted on: 12 February 2020
  • By: Shalini.Sharma

The first clinical trial specifically designed to test the safety of the monthly dapivirine vaginal ring in pregnant women has begun in southern and eastern Africa. The National Institutes of Health-funded study also will test the safety of a daily oral antiviral tablet for HIV pre-exposure prophylaxis (PrEP) in pregnant women and will assess how much they accept and use these two HIV prevention tools. The study will complement an ongoing NIH-funded trial of PrEP in adolescents and young women during pregnancy and the first six months after birth. PrEP is available in some countries and is being rolled out in others, while the dapivirine ring is under regulatory review by the European Medicines Agency for potential use in sub-Saharan Africa.

Ministers to agree new global road safety agenda to 2030 : WHO

  • Posted on: 12 February 2020
  • By: Shalini.Sharma

Government ministers and senior officials from over 100 countries will meet in Stockholm, Sweden from 19-20 February to discuss new steps to halve road traffic deaths and injuries by 2030, in line with global targets agreed in the United Nations Sustainable Development Goals (SDGs).

FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals

  • Posted on: 12 February 2020
  • By: Shalini.Sharma

Genome editing is a groundbreaking technology used to introduce intentional genomic alterations in animals and has the potential to improve human and animal health, animal well-being and to enhance food production and quality. It is paramount, however, that as we move forward, we maintain standards of safety and effectiveness.

FDA Authorizes Marketing of First Cardiac Ultrasound Software That Uses Artificial Intelligence to Guide User

  • Posted on: 12 February 2020
  • By: Shalini.Sharma

U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality.

FIP issued guidelines for Pharmacists on how to deal with the latest coronavirus outbreak

  • Posted on: 12 February 2020
  • By: PharmaTutor News

The roles that pharmacists in community, hospital and clinical biology can play in preventing the spread of the new coronavirus 2019-nCoV and supporting the efficient management of infection by healthcare systems are outlined in a new document published by the International Pharmaceutical Federation (FIP). The document was developed by an emergency taskforce set up by FIP following the World Health Organization’s declaration that the outbreak of 2019-nCoV constitutes a public health emergency of international concern.

Cipla Sa Signs Agreement for Anti-Psychotic Drug

  • Posted on: 11 February 2020
  • By: PharmaTutor News

As part of its quest to provide access to life-saving medication and making a difference in the lives of patients, Cipla Medpro South Africa (Pty) Limited (“Cipla Medpro”), wholly-owned subsidiary of Cipla Limited, India (“Cipla”) and South Africa’s third largest pharmaceutical company in the private sector, has recently concluded an exclusive agreement (the “Agreement”) securing originator and authorised generic brands of an atypical anti-psychotic drug, Quetiapine (the “Medicine”).

Pages